| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2000029977 |
The study of Ruxolitinib as a front-line Therapy for pediatric Hemophagocytic Lymphohistiocytosis Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health |
hemophagocytic lymphohistiocytosis |
Therapy Study |
Post-market |
2020-02-18 | 1329 | Patient list |